Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV

• Main Authors: Wang-Da Liu (Author), Man Wai Pang (Author), Jann-Tay Wang (Author), Hsin-Yun Sun (Author), Yu-Shan Huang (Author), Kuan-Yin Lin (Author), Un-In Wu (Author), Guei-Chi Li (Author), Wen-Chun Liu (Author), Yi-Ching Su (Author), Pu-Chi He (Author), Chia-Yi Lin (Author), Chih-Yu Yeh (Author), Yu-Chen Cheng (Author), Yi Yao (Author), Yi-Ting Chen (Author), Pei-Ying Wu (Author), Ling-Ya Chen (Author), Yu-Zhen Luo (Author), Hsi-Yen Chang (Author), Wang-Huei Sheng (Author), Szu-Min Hsieh (Author), Sui-Yuan Chang (Author), Chien-Ching Hung (Author), Shan-Chwen Chang (Author)
• Format: Book
• Published: Elsevier, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: A community COVID-19 outbreak caused by the B.1.1.7 SARS-CoV-2 variant occurred in Taiwan in May 2021. High-risk populations such as people living with HIV (PLWH) were recommended to receive two doses of COVID-19 vaccines. While SARS-CoV-2 vaccines have demonstrated promising results in...